A citation-based method for searching scientific literature

Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
Times Cited: 294



Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg, Dominique Valeyre, Roland M du Bois. Lancet 2011
Times Cited: 1110




List of shared articles



Times cited

Pharmacological management of Idiopathic Pulmonary Fibrosis: current and emerging options.
Athina Trachalaki, Mujammil Irfan, Athol U Wells. Expert Opin Pharmacother 2021
3

A dry powder inhalable formulation of salvianolic acids for the treatment of pulmonary fibrosis: safety, lung deposition, and pharmacokinetic study.
Linxia Jiang, Yijun Li, Jiaqi Yu, Jianhong Wang, Jiarui Ju, Jundong Dai. Drug Deliv Transl Res 2021
0

MAP3K8 Regulates Cox-2-Mediated Prostaglandin E2 Production in the Lung and Suppresses Pulmonary Inflammation and Fibrosis.
Markella Zannikou, Ilianna Barbayianni, Dionysios Fanidis, Theodora Grigorakaki, Evlalia Vlachopoulou, Dimitris Konstantopoulos, Maria Fousteri, Ioanna Nikitopoulou, Anastasia Kotanidou, Eleanna Kaffe,[...]. J Immunol 2021
0

Hermansky-Pudlak syndrome pulmonary fibrosis: a rare inherited interstitial lung disease.
Tadafumi Yokoyama, Bernadette R Gochuico. Eur Respir Rev 2021
2

New insights into the Hippo/YAP pathway in idiopathic pulmonary fibrosis.
Mingyao Sun, Yangyang Sun, Ziru Feng, Xinliang Kang, Weijie Yang, Yongan Wang, Yuan Luo. Pharmacol Res 2021
1

Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
Chiel van Geffen, Astrid Dei├čler, Markus Quante, Harald Renz, Dominik Hartl, Saeed Kolahian. Front Immunol 2021
1

COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.
Alison E John, Chitra Joseph, Gisli Jenkins, Amanda L Tatler. Immunol Rev 2021
12

A novel multikinase inhibitor SKLB-YTH-60 ameliorates inflammation and fibrosis in bleomycin-induced lung fibrosis mouse models.
Hongyao Liu, Xiuli Wu, Cailing Gan, Liqun Wang, Guan Wang, Lin Yue, Zhihao Liu, Wei Wei, Xingping Su, Qianyu Zhang,[...]. Cell Prolif 2021
3